Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Erratum: Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma.
Journal: JCO precision oncology
Published: July 16, 2026
Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma.
Journal: JCO precision oncology
Published: February 13, 2026
The Microbiome and Genitourinary Cancers: A New Frontier.
Journal: Cancers
Published: October 03, 2025
Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer.
Journal: Cancers
Published: July 07, 2023
COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma.
Journal: The Lancet. Oncology
Published: March 15, 2021
Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-naïve prostate cancer cells.
Journal: Aging
Published: February 06, 2020
Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors.
Journal: JNCI cancer spectrum
Published: January 30, 2020
Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer.
Journal: Cell death & disease
Published: December 20, 2019
The Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020?
Journal: Clinical genitourinary cancer
Published: August 28, 2019
Last Updated: 09/26/2026